Featured Research

from universities, journals, and other organizations

Nurses eliminate pressure ulcers in premature infants

Date:
November 20, 2013
Source:
Loyola University Health System
Summary:
Infants born prematurely are at a significantly increased risk for pressure ulcers, yet nurses at one hospital have been able to eliminate this threat for patients in the hospital’s neonatal intensive care unit.

Infants born prematurely are at a significantly increased risk for pressure ulcers, yet nurses at Loyola University Health System have been able to eliminate this threat for patients in the hospital's neonatal intensive care unit.

"While the toll of pressure ulcers has been recognized in adults for decades, the same concerns have only been reported in premature infants in recent years," said Lisa Festle, MSN, RNC-NIC, APRN/CNS, LUHS. "Our nurses recognized the serious threat pressure ulcers pose to infants and implemented a program to protect the delicate skin of our youngest patients."

Pressure ulcers occur at a rate as high as 25 percent in high-risk premature infants. These infants are at a greater risk for pressure ulcers due to their extremely low birth weight, immature skin, need for medical equipment, immobility and imbalances in oxygen and blood flow. The most common locations for pressures ulcers in premature infants are the back of the head and the openings of the nose.

Loyola nurses gathered a multidisciplinary team of specialists to review literature and identify skin risk-assessment tools, skin-care products and pressure-reducing aids to help prevent pressure ulcers in this vulnerable population.

The group modified the Neonatal/Infant Braden Q Skin Risk Assessment Tool to detect pressure ulcer risk. They then tested the tool, developed intervention guidelines, implemented electronic medical record documentation and provided ongoing education to nurses.

"The health-care system has not had a consistent way to assess the risk for skin breakdown in premature infants," said Barbara Hering, MSN, RNC-NIC, APRN/CNS, LUHS. "This program allowed our nurses to more easily recognize at-risk patients and implement interventions earlier to prevent pressure ulcers and subsequent complications."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Nurses eliminate pressure ulcers in premature infants." ScienceDaily. ScienceDaily, 20 November 2013. <www.sciencedaily.com/releases/2013/11/131120143635.htm>.
Loyola University Health System. (2013, November 20). Nurses eliminate pressure ulcers in premature infants. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/11/131120143635.htm
Loyola University Health System. "Nurses eliminate pressure ulcers in premature infants." ScienceDaily. www.sciencedaily.com/releases/2013/11/131120143635.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins